China National Accord Medicines Corp Ltd (200028) — Strategic Asset Allocation Index
China National Accord Medicines Corp Ltd (200028) has a Strategic Asset Allocation Index of 17.5% as of September 2023. Strategic assets (PP&E of HK$3.58 Billion plus long-term investments of HK$-) total HK$3.58 Billion, measured against net assets of HK$20.47 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.
SAAI
Strategic Assets
PP&E
Net Assets
China National Accord Medicines Corp Ltd Strategic Asset Allocation Index (2015–2022)
This chart shows how China National Accord Medicines Corp Ltd's Strategic Asset Allocation Index has evolved across 8 annual periods from 2015 to 2022. As of September 2023, the index stands at 17.5%, representing strategic assets of HK$3.58 Billion against net assets of HK$20.47 Billion HKD. Explore 200028 cash flow metrics to assess how effectively this company generates cash.
Annual Strategic Asset Allocation Index for China National Accord Medicines Corp Ltd (2015–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for China National Accord Medicines Corp Ltd from 2015 to 2022, covering 8 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see China National Accord Medicines Corp Ltd (200028) total market value.
| Year | SAAI | Strategic Assets (HKD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 17.5% | HK$3.41 Billion | HK$3.41 Billion | HK$- | HK$19.44 Billion | ▼ -1.9 pp |
| 2021 | 19.4% | HK$3.49 Billion | HK$3.49 Billion | HK$- | HK$18.02 Billion | ▲ +0.1 pp |
| 2020 | 19.3% | HK$3.26 Billion | HK$3.26 Billion | HK$- | HK$16.89 Billion | ▲ +1.5 pp |
| 2019 | 17.8% | HK$2.73 Billion | HK$2.73 Billion | HK$- | HK$15.36 Billion | ▼ -1.5 pp |
| 2018 | 19.3% | HK$2.68 Billion | HK$644.35 Million | HK$2.03 Billion | HK$13.91 Billion | ▼ -3.3 pp |
| 2017 | 22.6% | HK$2.24 Billion | HK$574.66 Million | HK$1.66 Billion | HK$9.93 Billion | ▲ +0.6 pp |
| 2016 | 22.0% | HK$1.96 Billion | HK$534.07 Million | HK$1.43 Billion | HK$8.91 Billion | ▼ -9.7 pp |
| 2015 | 31.7% | HK$1.77 Billion | HK$1.57 Billion | HK$192.96 Million | HK$5.57 Billion | — |